Clinical Trials Logo

Advanced Hodgkin Lymphoma clinical trials

View clinical trials related to Advanced Hodgkin Lymphoma.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03517137 Active, not recruiting - Clinical trials for Advanced Hodgkin Lymphoma

Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study

COBRA
Start date: August 1, 2019
Phase: Phase 2
Study type: Interventional

The main objective of this trial is to assess whether treatment adaptation based on a very early FDG-PET/CT results in improved efficacy while minimizing treatment toxicity in advanced stage Hodgkin Lymphoma (HL) patients treated with brentuximab vedotin (BV)-containing regimens.